References for Thera Blend Oils

1. Hunt SM, Groff JL.  Advanced Nutrition and Human Metabolism.  West Pub. Co., NY, pp 100-103, 1990.
2.  Gray JB, Martinovic AM.  Eicosanoids and essential fatty acid modulation in chronic disease and the chronic fatigue syndrome.  Med Hypoth 43:31-42, 1994
3. Champe PC, Harvey RA.  Lippincott's Illustrated Reviews: Biochemistsry  Lippincott Co., Philadelphia, pp 177, 1987.
4. Yamanak WK, et al.  Essential fatty acids deficiency in humans.  Prog Lipd Res  19:187-215, 1981.
5. Rudin DO.   The Omega 3 Phenomenon.  Rawson Assoc., New York, 1987.
6. Champe PC, Harvey RA.  Lippincott's Illustrated Reviews: Biochemistsry  Lippincott Co., Philadelphia, pp 152, 1987.
7. Champe PC, Harvey RA.  Lippincott's Illustrated Reviews: Biochemistsry  Lippincott Co., Philadelphia, pp 170, 1987.
8. Sears B.  Essential fatty acids and dietary endocrinology: A hypothesis for cardiovascular treatment.  J Adv Med 6(4):211-224, 1993.
9. Simopoulous AP. Omega-3 fatty acids in health and disease and in growth
and development.  Am J Clin Nutr 54:438-463, 1991.
10. Cho SH, Choi YS.  Lipid peroxidation and antioxidant status is affected by different vitamin E levels feeding fish oil.  Lipids 29(1):43-47, 1994.
11. Kinesella JE.  Food lipids and fatty acids: Importance in food quality, nutrition and health.  Food Tech Oct 88:124-145.
12. Anderson AJC.  Refining of Fats and Oils. Williams (ed).  Pergamon Press, Elmsford, NY, 1962.
13. Eramus U. Fats and Oils. Alive Books, Vancouver, Canada, pp 84-89, 1986.
14. Raloff J.  Margarine is anything but a marginal fat.  Sci News May  94:325.
15. Mensink RP, Katan MB.  Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects.  N Eng J Med 323:439-445, 1990.
16. Kinsella JE, et al.  Metabolism of trans fatty acids with emphasis on the effects of trans, trans-octadecadienoate on lipid composition, essential fatty acids and prostaglandins - an overview.  Am J Clin Nutri 34:2307-2318, 1981.
17. Raederstorff D,et al.  Polyunsaturated fatty acid metabolism of human skin fibroblasts during cellular aging. Int J Vitam Nutr Res 65(1):51-5, 1995.
18. Umezawa M, et al.  Dietary alpha-linolenate/linoleate balance influences learning and memory in the senescence-accelerated mouse (SAM).  Brain Res 669(2):225-33, 1995 .
19.  Delion S, et al.  Alpha-Linolenic acid dietary deficiency alters age-related
changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex.  J Neurochem 66(4):1582-91, 1996.
20. Gaullier JM, et al.  Glutathione peroxidase and glutathione reductase activities towards glutathione-derived antioxidants.  Biochem Biophys Res Comm 203(3):1668-1874, 1994.
21. Christon R, et al.  Dietary polyunsaturated fatty acids and aging modulate glutathione-related antioxidants in rat liver.  J Nutr 125(12):3062-70, 1995.
22. Wright S, Burton JL.  Oral evening primrose-seed oil improves atopic eczema.  Lancet Nov 20: 1120-1122, 1982.
23. Horrobin DF, et al.  The nutritional regulation of T-lymphocyte function.  Med Hypoth 5:969-985, 1979.
24. Galland L. Increased requirements for essential fatty acids in atopic individuals: a review with clinical description.  J Am Coll Nutr 5:213-228, 1986.
25. Karmali RA.  Fatty acids: Inhibition of tumorigenesis.  Am J Clin Nutr 45:225-229, 1987.
26. Van der Merwe CF, et al.  Oral gamma-linolenic acid in 21 patients with unteatable malignancy.  Br J Clin Pract 41:907-915, 1987.
27. Begin ME, Ells G, Das UN, Horrobin DF.  Polyunsaturated fatty acid-induced cytotoxicity against tumour cells and its relationship to lipid perosidation.  J Natl Cancer Inst 77:1053-1062, 1986.
28. Budwig J. Essential fatty acids in the vital function of man.  Townsend Lett Feb/Mar 1991:173-176.
29.  Eramus U. Fats and Oils. Alive Books, Vancouver, Canada, pp 267-276, 1986.
30. Horrobin DF.  The possible roles of prostaglandin E1 and of essential fatty acids in mania, depression and alcoholism.  Prog Lipid ZRes 20:539-541, 1981. 
31. Homan CP, Bell AFJ.  A trial of eveing primrose oil in the treatment of chronic schizophrenia.  J Orthomol Psychiatry 127:591-591, 1975.
32. Booyens J, van der Merwe CF.  Chronic arachidonic acid eicosanoid imbalance: a common feature in coronary artery disease, hypercholesterolemia, cancer and other important disease.  Significance of desaturase enzyme inhibition and of the arachidonic acid desaturase-independent pathway.  Med Hypoth 18:53-60, 1985.
33. Harris WS.  Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review.  J Lipid Res 30(6):785-807, 1989..
34. Chaintreuil J, et al.  Effects of dietary gamma-linolenate supplementation on serum lipids and platelet function in insulin-dependent diabetic patients.  Hum Nutr Clin Nutr 38:121-130, 1984.
35. Karmazyn M,et al.  The mechanism of coronary artery spasm: foles of oxygen , prostaglandins, sex hormones and smokeing.  Med Hypoth 5:447-452, 1979.
36. Vericel E, et al.  Effects of linoleic acid and gamma-linolenic acid intake on platelet function in elderly people.  Thromb Res 42:499-509, 1986.
37. Hansen TM, et al.  Treatment of Rheumatoid arthritis with prostaglandin E1 precursors, cis-linoleic acid and gamma-linolenic acid.  Scand J Rheum 12:183-185, 1982.
38. Kremer JM, Robinson DR.  Studies of dietary supplementation with w-3 fatty acids in patients with rheumatoid arthritis.  World Rev Nutr Diet  66:367-382, 1991.
39.  Lorenz R,  et al.  Supplementation with n-3 fatty acids from fish oil in chronic inflammatoruy bowel disease-a randomized, placebo-controlled, double-blind cross-over trial.  J Intern Med Suppl 225(731):225-232, 1989.
40. Arm JP, Lee TH.  The use of fish oil in bronchial asthma.  Allergy Proc 10(3):185-187, 1989.
41. Godfrey DG, et al.  Effects of dietary supplements on autoimmunity in the MRL/1 pr mouse: A preliminary investigation.  Ann Rheum Dis 45:539-549, 1986.
42.  Karmali RA, et al.  Prostaglandins and essential fatty acids in regulation of autoimmunity and development of antibodies to DNA in NZB and NZW F1 mice.  Prog Lip Res 20:655-661, 1982.
43. Manthrope R. Hagen PS, Prause JU.  Primary Sjogren's syndrome treated with AEFAMOL/Efavit.  A double-blind cross-over investigation.  Rheumatol Int 4:165-167, 1984.
44. Gray JB, Martinovic AM.  Eicosanoids and essential fatty acid modulation in chronic disease and the chronic fatigue syndrome.  Med Hypoth 43:31-42, 1994.
45. Critchley EMR.  Evening primrose oil in Parkinsonian and other tremors: a preliminary study.  In: Horrobin DF, ed. Clinical uses of essential fatty acids. Montreal: Eden Press, pp 205-208, 1982.
46. Mertin H, Meade CJ.  Relevance of fatty acids in MS.  Br Med Bull 33:67-71, 1977.
47. Bates D, Fawcett PR, Shaw DA, Weightman D.  Polyunsaturated fatty aids in treatment of acute remitting mulitple sclerosis.  Br Med J 2:1390-1391, 1978.
48. Field EJ, Joyce G.  Multiple sclerosis: effect of gamma-linolenate administration upon membranes and the need for extended clinical trials of unsaturated fatty acids.  Eur Neurol 22:78-83, 1983.
49. Jamal GA, et al.  Gamma-linolenic acid in diabetic neuropathy.  Lancet i:1098-1100, 1986.
50. Ockerman PA, Bachrack I, Glans S, Rassner S.  Evening primrose oil as a treatment of the premenstrual syndrome.  Recent Adv Clin Nutr 2:404-405, 1986.
51. Horrobin DF.  The role of seential fatty acids and prostaglandins in the premenstrual syndrome.  J Reprod Med  28:465-468, 1986.
52. Pye JK, Mansel RE, Hughes LE.  Clinical experience of drug treatments for mastalgia.  Lancet 2:373-376, 1985.
53. Holman R, et al.  Deficiency of EFAs and membrane fluidity during pregnancy and lactation.  Biochem Nat Acad Sci 88:4835-4839, 1991.
54. Wright S.  Essential fatty acids in clinical dermatology.  J Nutr Med 1:301-313, 1990.
55. Wright S, Burton JL.  Evening primrose seed oil improves atopic eczema.  Lancet ii:1120-1122, 1982.
56. Bittiner SB, Tucker WFG, Cartwright I, Bleehen SS.  A double blind randomised, pacebo-controlled trial of fish oil in psoriasis.  Lancet i:378-380, 1988.
57.  Downin DT, Stweart ME, Wertz PW, Strauss JS.  Essential fatty acids and acne.  J Am Acad Dermat 14:221-4, 1986.
58. Nedergaard J, Becker W, Cannon B.  Effects of dietary essential fatty acids on active thermogenin content in rat brown adipose tissue.  J Nutr 113:1717-1724, 1983.
59. Mir MA, et al.  The effects of evening primrose oil on erythrocyte sodium transport and obesity.  In: Horrobin DF, ed.  Clinical uses of essential fatty acids.  Montreal: Eden Press, pp 53-61, 1982.
60. Garcia CM, Carter J, Chou A.  Gamma linolenic acid causes weight loss and lower blood pressure in overweight patients with family history of obesity.  Swed J Biol Med 4:8-11, 1986.
61. Shukla VKS, Perkins.  The presence of oxidative polymeric materials in encapsulated fish oils.  Lipids 26:1-3, 1991.
62. Mest HJ, et al.  The influence of linseed oil on fatty acid pattern in phospholipids and thromboxane formation in platelets in man.  Klin Woschenschr 61:187-191, 1983.  
63. Mantzioris E, et al.  Dietary substitution with alph-linolenic rich vegetable oil increases eicosapentaenoic acid concentrations in tissues.  Am J Clin Nutr 59:1304-1309, 1994.
64. Horrobin DF.  Fatty acid metabolism in health and disease: the role of
delta-6-desaturase. Am J Clin Nutr 57(5 Suppl):732S-736S, 1993.
65. Leventhal L, et al.  Treatment of rheumatoid arthritis with gamma-linolenic acid.  Ann Int Med 119(9):433-467, 1993.
66. Brook J, et al.  Dietary soya lecithin decreases plasma triglycerides levels and platelet aggregation.  Biochem Med Metabol Biol 35:31-39, 1986.
67. Cohen LA, Wynder EI.  Do dietary monounsaturated fatty acids play a protective role in carcinogenesis and cardiovascular disease?  Med Hypoth 31:83-89, 1990.
68. Satoh A, et al. Antimicrobial benzopyrans from the receptacle of sunflower.  Biosci Biotechnol Biochem 60(4):664-5, 1996.
69. Frawley D. Ayruvedic Healing, Passage Press, Salt Lake City, Utah, 1989.
70. Rickard SE,  et al.  Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. J Nutr 126(8):2012-2019, 1996.
71.  Matsumura Y, et al.  Antihypertensive effect of sesamin. I. Protection against deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.  Biol Pharm Bull 18(7):1016-9,  1995. 
72. Ogawa H, et al. Sesame lignans modulate cholesterol metabolism in the stroke-prone spontaneously hypertensive rat.  Clin Exp Pharmacol Physiol 22( Suppl 1):S310-2, 1995.
73. Sauter M, et al.  Pharmazeut Ztg 130:73-75, 1985.
74. Hamvas A, et al.  (Mediflora 1988-1989) Dept. of Urol, Semmelweis Univ. Med. Sch, Budapest, Hungary.